Background Mass drug administration (MDA) with azithromycin is a cornerstone of the
trachoma elimination strategy. Although the global prevalence of active trachoma has …

Abstract Background. The World Health Organization recommends mass treatment as part of
a trachoma control strategy. However, scant empirical data from hyperendemic communities …

Background Trachoma, a neglected tropical disease, is caused by ocular infection with
Chlamydia trachomatis (Ct). The World Health Organization (WHO) recommends three …

Background An important component of the World Health Organization's comprehensive
trachoma elimination strategy is the provision of repeated annual mass azithromycin …

Background Antibiotics are a major tool in the WHO's trachoma control program. Even a
single mass distribution reduces the prevalence of the ocular chlamydia that causes …

Although trachoma mass drug administration (MDA) programs target ocular Chlamydia
trachomatis, the global trachoma control program does not monitor infection as a measure of …

Background. Trachoma, caused by repeated infections with ocular Chlamydia trachomatis,
is targeted for elimination using multiple annual rounds of mass drug administration (MDA) …

Background Community-wide mass antibiotic treatment is a central component of trachoma
control. The optimum frequency and duration of treatment are unknown. We measured the …

The World Health Organization (WHO) recommends continuing azithromycin mass drug
administration (MDA) for trachoma until endemic regions drop below 5% prevalence of …

Objectives To investigate risk factors for ocular Chlamydia trachomatis infection and active
trachoma, comparing communities receiving or not receiving an intervention programme of …